Blue Owl Capital Holdings LP

Related Filers (8)

Other (12)

13F-HR
Thursday, 2/15/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/11/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 5/11/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/12/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/11/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
D
Wednesday, 6/2/2021
Exempt (Private) Offering
Show More

Ownership (8)

SC 13G
Wednesday, 2/14/2024
enGene Holdings Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Repare Therapeutics Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Larimar Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
PLIANT THERAPEUTICS, INC.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Cullinan Oncology, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Orchard Therapeutics plc: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Syros Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Tourmaline Bio, Inc.: Major Shareholders
Show More